Tysabri Taking Biogen Idec To New HighsForbesFounded in 1985, Biogen has several candidates in its pipeline, including BG-12 (multiple sclerosis), daclizumab (multiple sclerosis), Factor VIII (hemophilia A) and Factor IX (hemophilia B) among others. So…
Rotary welcomes heart transplant recipient
Inside Judy Meikle’s chest beats the heart of Corporal Benjamin S. Kopp, a young U.S. Army Ranger who died from combat wounds suffered in Afghanistan. The Winnetka resident recipient spoke recently about her gratitude and the importance of organ dona…
Children's heart disease no longer a death sentence
One of the world's longest living heart transplant recipients says heart disease is no longer a death sentence.
SYMPLICITY HTN-3 Clinical Trial at Sharp Memorial Hospital Investigates Radio Frequency as Possible Treatment for …
SAN DIEGO, Sept. 24, 2012 /PRNewswire/ — When multiple medications prove ineffective, patients with high blood pressure are currently left with few treatment options. Sharp Memorial Hospital was the first …
Free Kidney Screening This Tuesday
The National Kidney Foundation to hold kidney health screening Tuesday, September 25 at "Copper Top Church."
Free Kidney Screening This Tuesday – WDIO-TV
WDIO-TVFree Kidney Screening This TuesdayWDIO-TVThat is why the NFK is holding a free kidney health screening Tuesday, September 25 from 3 p.m. until 7 p.m. It is part of the Kidney Early Evaluation Program (KEEP), an effort to get people thinking abou…
Heart Failure Drug Promising in Phase III Trial – MedPage Today
TopNews New ZealandHeart Failure Drug Promising in Phase III TrialMedPage TodayA novel agent for treating acute heart failure met one of its two primary endpoints in reducing dyspnea, but which one has not yet been divulged, according to a statement fr…
Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection
Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for tacrolimus extended release capsules for the pr…
Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection – News-Medical.net
Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejectionNews-Medical.netAstellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced it has submitted a Ne…
Ceva Sante Animale launches heart failure therapy for dogs – Zenopa
Ceva Sante Animale launches heart failure therapy for dogsZenopaCeva Sante Animale has launched Cardalis, a canine heart failure treatment that combines two proven active ingredients. The unique therapy combines benazepril and spironolactone into a sin…